Literature DB >> 25550840

Blood vessel invasion and other variables as predictors of long-term survival in Japanese and British patients with primary invasive breast cancer.

Takao Kato1, Francesco Pezzella2, Graham Steers2, Leticia Campo2, Russell D Leek2, Helen Turley2, Shingo Kameoka3, Toshio Nishikawa4, Adrian L Harris5, Kevin C Gatter2, Stephen Fox6.   

Abstract

This study was undertaken to investigate the associations of blood vessel invasion (BVI), lymphatic vessel invasion (LVI) or other variables and long-term survival in 173 Japanese and 184 British patients with primary invasive breast cancer, and whether they are associated with survival differences between Japanese and British patients. BVI was detected by objective methods, using both factor VIII-related antigen (F-VIII) staining and elastica van Gieson (E v G) staining. BVI was classified into three subtypes. 1) BVI e, BVI detected by E v G staining alone, 2) BVI f, BVI detected by F-VIII staining alone, 3) BVIef, BVI evaluated by combining BVIf and BVIe. LVI was also detected by objective methods, using lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1) staining alone. There was a borderline significance between the frequencies for BVIef of British patients and those of Japanese patients (8.2% vs 3.5%; P = 0.06) but not for LVI (P = 0.36). British patients had a significantly worse relapse-free survival (RFS) and overall survival (OS) than Japanese patients (P < 0.01, P < 0.01, respectively) even though their tumors were smaller and more ER-positive with a similar prevalence of lymph-node involvement. LVI was not significantly associated with RFS and OS, however, BVIef positive tumors had a significantly worse RFS and OS compared with BVIef negative patients, after statistical adjustment for the other variables (P = 0.02, P = 0.01, respectively). The present study shows that BVIef variability might contribute to the Japanese and British disparities in breast cancer outcomes.

Entities:  

Keywords:  Breast cancer; KDR/Flk-1; LYVE-1 staining; blood vessel invasion; ethnicity; lymphatic vessel invasion

Mesh:

Substances:

Year:  2014        PMID: 25550840      PMCID: PMC4270576     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  43 in total

1.  Age at onset as an indicator of familial risk of breast cancer.

Authors:  E B Claus; N J Risch; W D Thompson
Journal:  Am J Epidemiol       Date:  1990-06       Impact factor: 4.897

2.  The prognostic value of lymphatic and blood vessel invasion in operable breast cancer.

Authors:  R Lauria; F Perrone; C Carlomagno; M De Laurentiis; A Morabito; C Gallo; E Varriale; G Pettinato; L Panico; G Petrella
Journal:  Cancer       Date:  1995-11-15       Impact factor: 6.860

Review 3.  Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition.

Authors:  J A Nagy; L F Brown; D R Senger; N Lanir; L Van de Water; A M Dvorak; H F Dvorak
Journal:  Biochim Biophys Acta       Date:  1989-02

4.  Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation.

Authors:  L A Liotta; J Kleinerman; G M Saidel
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

5.  Racial differences in survival of female breast cancer in the Detroit metropolitan area.

Authors:  M S Simon; R K Severson
Journal:  Cancer       Date:  1996-01-15       Impact factor: 6.860

6.  Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients.

Authors:  S B Fox; R D Leek; J Bliss; J L Mansi; B Gusterson; K C Gatter; A L Harris
Journal:  J Natl Cancer Inst       Date:  1997-07-16       Impact factor: 13.506

7.  Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells.

Authors:  Maryam R Sartippour; Zhi-Ming Shao; David Heber; Perrin Beatty; Liping Zhang; Canhui Liu; Lee Ellis; Wen Liu; Vay Liang Go; Mai N Brooks
Journal:  J Nutr       Date:  2002-08       Impact factor: 4.798

8.  Blood vessel invasion and axillary lymph node involvement as prognostic indicators for human breast cancer.

Authors:  R A Weigand; W M Isenberg; J Russo; M J Brennan; M A Rich
Journal:  Cancer       Date:  1982-09-01       Impact factor: 6.860

9.  Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.

Authors:  A D Thor; I I Moore DH; S M Edgerton; E S Kawasaki; E Reihsaus; H T Lynch; J N Marcus; L Schwartz; L C Chen; B H Mayall
Journal:  J Natl Cancer Inst       Date:  1992-06-03       Impact factor: 13.506

10.  Peritumoral lymphatic invasion in patients with node-negative mammary duct carcinoma.

Authors:  C G Clemente; P Boracchi; S Andreola; M Del Vecchio; P Veronesi; F O Rilke
Journal:  Cancer       Date:  1992-03-15       Impact factor: 6.860

View more
  2 in total

Review 1.  The prognostic influence of lymphatic endothelium-specific hyaluronan receptor 1 in cancer: A systematic review.

Authors:  Sini Karinen; Roosa Hujanen; Tuula Salo; Abdelhakim Salem
Journal:  Cancer Sci       Date:  2021-11-24       Impact factor: 6.716

2.  Defining lymphocyte-predominant breast cancer by the proportion of lymphocyte-rich stroma and its significance in routine histopathological diagnosis.

Authors:  Haruo Ohtani; Kazuko Mori-Shiraishi; Morio Nakajima; Hamaichi Ueki
Journal:  Pathol Int       Date:  2015-11-04       Impact factor: 2.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.